The potential of CXCL5 as a target for liver cancer – what do we know so far?

Bibliography

• Walz A, Burgener R, Car B, et al. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med 1991;174(6):1355-62
   PubMed Web of Science ®Google Scholar
• Xu X, Huang P, Yang B, et al. Roles of CXCL5 on migration and invasion of liver cancer cells. J Transl Med 2014;12:193
   Google Scholar
• Zhou SL, Dai Z, Zhou ZJ, et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012;56(6):2242-54
   PubMed Web of Science ®Google Scholar
• Zhou SL, Dai Z, Zhou ZJ, et al. CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils. Carcinogenesis 2014;35(3):597-605
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang L, Xu J, et al. Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma. J Surg Res 2011;166(2):241-6
   Google Scholar
• Li A, King J, Moro A, et al. Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol 2011;178(3):1340-9
   PubMed Web of Science ®Google Scholar
• Hsu YL, Hou MF, Kuo PL, et al. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene 2013;32(37):4436-47
   Google Scholar
• Kuo PL, Chen YH, Chen TC, et al. CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway. J Cell Physiol 2011;226(5):1224-31
   Google Scholar
• Zheng J, Zhu X, Zhang J. CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration. Biochem Biophys Res Commun 2014;446(1):18-24
   PubMed Web of Science ®Google Scholar
• Kuo PL, Huang MS, Hung JY, et al. Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression. Int J Cancer 2014;135(1):96-108
   Google Scholar
• Huang P, Xu X, Wang L, et al. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment. J Cell Mol Med 2014;18(2):218-30
   PubMed Web of Science ®Google Scholar
• Ruddy MJ, Shen F, Smith JB, et al. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 2004;76(1):135-44
   PubMed Web of Science ®Google Scholar
• Ma S, Cheng Q, Cai Y, et al. IL-17A produced by gamma delta T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res 2014;74(7):1969-82
   Google Scholar
• Chandrasekar B, Melby PC, Sarau HM, et al. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem 2003;278(7):4675-86
   Google Scholar
• Kachroo P, Lee M H, Zhang L, et al. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res 2013;32:97
   PubMed Web of Science ®Google Scholar
• Tetreault M P, Wang M L, Yang Y, et al. Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology 2010;139(6):2124-34
   Google Scholar
• Thobe MN, Gurusamy D, Pathrose P, et al. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene 2010;29(2):214-26
   Google Scholar
• Yoon KA, Cho HS, Shin HI, et al. Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration. Stem Cells Dev 2012;21(18):3391-402
   Google Scholar
• Zhang H, Xia W, Lu X, et al. A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients. PLoS One 2013;8(2):e57830
   Google Scholar
• Wang XD, Liotta L. Clinical bioinformatics: a new emerging science. J Clin Bioinforma 2011;1(1):1
   PubMedGoogle Scholar
• Wang XD. Role of clinical bioinformatics in the development of network-based Biomarkers. J Clin Bioinforma 2011;1(1):28
   Google Scholar
• Chen H, Wang X. Significance of bioinformatics in research of chronic obstructive pulmonary disease. J Clin Bioinforma 2011;1:35
   PubMedGoogle Scholar
• Chen H, Song Z, Qian M, et al. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med 2012;16(6):1286-97
   Google Scholar